Nightingale’s biomarker analysis platform is routinely used in world-class epidemiological and genetic studies. There are over 300 publications that have applied our method. See full list of publications here.

Metabolic risk factors

Metabolic biomarker profiling for identification of susceptibility to severe pneumonia and COVID-19 in the general population

Nightingale's blood biomarkers were used for prediction of severe pneumonia and COVID-19 hospitalisation in 105,146 plasma samples collected in the UK Biobank during 2007-2010.

Julkunen et al, ELife 2021

Read more